Pre Exposure Prophylaxis News and Research

RSS
HIV treatment drugs also help prevent HIV infection in high-risk men: Study

HIV treatment drugs also help prevent HIV infection in high-risk men: Study

iPrEx study: PrEP reduces HIV infection risk among gay, bisexual men

iPrEx study: PrEP reduces HIV infection risk among gay, bisexual men

iPrEx trial shows reduction in new HIV infections

iPrEx trial shows reduction in new HIV infections

iPrEx oral PrEP study achieves major milestone in HIV prevention research

iPrEx oral PrEP study achieves major milestone in HIV prevention research

Daily oral antiretroviral reduces HIV infection risk in MSM by 44%, study finds

Daily oral antiretroviral reduces HIV infection risk in MSM by 44%, study finds

CONRAD congratulates Global iPrEx study team for HIV prevention trial

CONRAD congratulates Global iPrEx study team for HIV prevention trial

New York Times examines HIV prevention products undergoing clinical trials

New York Times examines HIV prevention products undergoing clinical trials

CQ Healthbeat examines HIV prevention research funding

CQ Healthbeat examines HIV prevention research funding

Onconova Therapeutics to present Ex-RAD radioprotectant data at RRS Annual Meeting

Onconova Therapeutics to present Ex-RAD radioprotectant data at RRS Annual Meeting

AVAC welcomes new Global HIV Vaccine Enterprise Scientific Strategic Plan

AVAC welcomes new Global HIV Vaccine Enterprise Scientific Strategic Plan

AIDS 2010: Obama, Clinton vow U.S. support to global fight against HIV/AIDS

AIDS 2010: Obama, Clinton vow U.S. support to global fight against HIV/AIDS

AVAC releases GPP Guidelines at International AIDS Conference

AVAC releases GPP Guidelines at International AIDS Conference

Study marks significant milestone for microbicide research field, HIV prevention

Study marks significant milestone for microbicide research field, HIV prevention

Flat global funding for HIV prevention research could have serious consequences: Report

Flat global funding for HIV prevention research could have serious consequences: Report

New insights on early pathogenic events, strategies for preventing HIV infection

New insights on early pathogenic events, strategies for preventing HIV infection

Tenofovir gel reduces HIV by 39% in women: CAPRISA 004 study

Tenofovir gel reduces HIV by 39% in women: CAPRISA 004 study

AVAC applauds CAPRISA 004 microbicide gel trial for preventing sexual transmission of HIV infection

AVAC applauds CAPRISA 004 microbicide gel trial for preventing sexual transmission of HIV infection

Bill Gates calls for renewed focus on reducing new HIV infections

Bill Gates calls for renewed focus on reducing new HIV infections

New microbicide gel reduces woman's risk of being infected with HIV, genital herpes

New microbicide gel reduces woman's risk of being infected with HIV, genital herpes

AVAC Report surveys state of biomedical HIV prevention research

AVAC Report surveys state of biomedical HIV prevention research